Example: Heart Attack
Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Total 9779 results
-
NCT06371040Recruiting
-
NCT05717829Recruiting
-
NCT05687955RecruitingHip Dysplasia | Femoro Acetabular Impingement
-
NCT05068986RecruitingThe Frequency of ER Visits in Asthmatic Children
-
NCT04672733RecruitingChronic Inflammatory Demyelinating Polyneuropathy
-
NCT04575571RecruitingPsychosocial Impacts of the COVID-19 Pandemic
-
NCT04563832Recruiting
-
NCT04260711RecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive
-
NCT04064944Not yet recruiting
-
-
NCT06700616Active, not recruitingMyasthenia Gravis
-
NCT03955978Active, not recruitingEndometrial Cancer | Cancer of the Endometrium
-
NCT05132569Terminated
-
NCT03963310Completed
-
NCT07025122Enrolling by invitationMultiple Sclerosis | Fatigue in Multiple Sclerosis | GFAP | Neurofilaments Light Chains | HLA DRB 1501 | BCL6 (rs969625) | OS9 (rs701006)
-
NCT07002151CompletedRelapsing-remitting Multiple Sclerosis
-
NCT04701164CompletedGuillain-Barre Syndrome
-
NCT05403138Active, not recruitingNeuromyelitis Optica | Neuromyelitis Optica Spectrum Disorder | NMO Spectrum Disorder
-
NCT03825601CompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
-
-
NCT05581199Active, not recruitingChronic Inflammatory Demyelinating Polyneuropathy
-
NCT05154734CompletedNMO Spectrum Disorder
-
NCT02465359CompletedChronic Inflammatory Demyelinating Polyneuropathy
-
NCT03304054CompletedMyasthenia Gravis, Generalized
-
NCT03772717TerminatedChronic Inflammatory Demyelinating Polyneuropathy
-
NCT03737747CompletedPrediction by the Synek Score of Poor Neurological Outcome in Postanoxic Comatose Patients Treated With Induced Hypothermia
-
NCT01838174TerminatedMultiple Sclerosis
-
NCT02073279CompletedNeuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)
-
NCT03319732CompletedMultiple Sclerosis | Spasticity, Muscle
-
NCT01636544CompletedSquamous Cell Carcinoma of the Oral Cavity | Leukoplakia Oral
-
-
NCT01889186CompletedChronic Lymphocytic Leukemia | 17p Deletion | Cancer of the Blood and Bone Marrow
-
NCT04904640Completed
-
NCT01647880Terminated
-
NCT03653585CompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive
-
NCT03490539CompletedAutoimmune Diseases | Neurological Disorder
-
NCT02330965CompletedSecondary Progressive Multiple Sclerosis
-
NCT01647321CompletedSecondary Progressive Multiple Sclerosis
-
NCT02308137CompletedMultiple Sclerosis, Secondary Progressive
-
NCT00647348CompletedSecondary Progressive Multiple Sclerosis
-
NCT02296346TerminatedOpen-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis (MSECP)Secondary Progressive Multiple Sclerosis
-
NCT02276963CompletedNeuromyelitis Optica | Neuromyelitis Optica Spectrum Disorder
-
NCT01450488Completed
-
NCT03585569UnknownMultiple Sclerosis | Spasticity, Muscle
-
NCT03418337UnknownCompare the Response Rate of Atypical GERD After PPI Therapy
-
NCT03340259UnknownNewborn Infants With Enterostomy by Congenital Malformations of the Gastrointestinal Tract, Necrotizing Enterocolitis and Spontaneous Intestinal Perforation
-
NCT02133664CompletedMultiple Sclerosis | Cognition
-
NCT03045471UnknownTo Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
-
NCT01392300CompletedPost-stroke Spasticity of the Upper Limb